These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 16364831)
21. Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V. White HD; Gruber M; Feyzi J; Kaatz S; Tse HF; Husted S; Albers GW Arch Intern Med; 2007 Feb; 167(3):239-45. PubMed ID: 17296878 [TBL] [Abstract][Full Text] [Related]
22. Effects of supplementation with multivitamin and mineral on blood pressure and C-reactive protein in obese Chinese women with increased cardiovascular disease risk. Wang C; Li Y; Zhu K; Dong YM; Sun CH Asia Pac J Clin Nutr; 2009; 18(1):121-30. PubMed ID: 19329405 [TBL] [Abstract][Full Text] [Related]
23. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study. Okin PM; Wachtell K; Kjeldsen SE; Julius S; Lindholm LH; Dahlöf B; Hille DA; Nieminen MS; Edelman JM; Devereux RB Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428 [TBL] [Abstract][Full Text] [Related]
24. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction. Wald DS; Law M; Mills S; Bestwick JP; Morris JK; Wald NJ Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791 [TBL] [Abstract][Full Text] [Related]
25. Is computer-assisted, long-term warfarin therapy safe and efficacious for patients with nonrheumatic atrial fibrillation? Perez-Gomez F Nat Clin Pract Cardiovasc Med; 2005 Feb; 2(2):82-3. PubMed ID: 16265377 [No Abstract] [Full Text] [Related]
26. Comparison of management patterns and clinical outcomes in patients with atrial fibrillation in Canada and the United States (from the analysis of the Atrial Fibrillation Follow-up Investigation of Rhythm Management [AFFIRM] database). O'Hara GE; Charbonneau L; Chandler M; Vidaillet HJ; Philippon F; Sami M; Rocco TA; Padder FA; Champagne J; Pratt CM; Coutu B; Wyse DG; Am J Cardiol; 2005 Sep; 96(6):815-21. PubMed ID: 16169368 [TBL] [Abstract][Full Text] [Related]
27. Use of sibutramine in obese mexican adolescents: a 6-month, randomized, double-blind, placebo-controlled, parallel-group trial. García-Morales LM; Berber A; Macias-Lara CC; Lucio-Ortiz C; Del-Rio-Navarro BE; Dorantes-Alvárez LM Clin Ther; 2006 May; 28(5):770-82. PubMed ID: 16861099 [TBL] [Abstract][Full Text] [Related]
28. A randomized, double-blind, placebo-controlled, parallel-group study to assess the efficacy and safety of dual ACE/NEP inhibitor GW660511X in mild-to-moderate hypertensive patients. Johnson AG; Pearce GL; Danoff TM J Hum Hypertens; 2006 Jul; 20(7):496-503. PubMed ID: 16543907 [TBL] [Abstract][Full Text] [Related]
29. Calcium chloride before i.v. diltiazem in the management of atrial fibrillation. Kolkebeck T; Abbrescia K; Pfaff J; Glynn T; Ward JA J Emerg Med; 2004 May; 26(4):395-400. PubMed ID: 15093843 [TBL] [Abstract][Full Text] [Related]
30. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension. Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280 [TBL] [Abstract][Full Text] [Related]
31. A cautionary note on data sources for evidence-based clinical decisions: warfarin and stroke prevention. Thomson R; Eccles M; Wood R; Chinn DJ Med Decis Making; 2007; 27(4):438-47. PubMed ID: 17641140 [TBL] [Abstract][Full Text] [Related]
32. [Comparative study of warfarin and aspirin for stroke prevention in elderly patients with atrial fibrillation]. Han W; Shen DT; Wang YM Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):851-2, 855. PubMed ID: 16793618 [TBL] [Abstract][Full Text] [Related]
33. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy. Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679 [TBL] [Abstract][Full Text] [Related]
34. A double-blind, controlled, multicenter, randomized study comparing the antihypertensive effectiveness and tolerance of a daily dose of two nifedipine formulations: nifedipine microgranules versus nifedipine osmotic pump. de Roa ER; Botero R; Octavio JA; Berrizbeitia ML; Mayorca E; Castro P; Miranda R; Valecillo E; Aroca G; Aza G; González M Am J Ther; 2007; 14(2):140-6. PubMed ID: 17414581 [TBL] [Abstract][Full Text] [Related]
35. Effect of pravastatin on blood pressure in people with cardiovascular disease. Tonelli M; Sacks F; Pfeffer M; Lopez-Jimenez F; Jhangri GS; Curhan G J Hum Hypertens; 2006 Aug; 20(8):560-5. PubMed ID: 16625234 [TBL] [Abstract][Full Text] [Related]
36. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?]. Selçuk H; Selçuk MT; Maden O Anadolu Kardiyol Derg; 2007 Mar; 7(1):54-8. PubMed ID: 17347079 [TBL] [Abstract][Full Text] [Related]
37. Randomized study of traditional versus aggressive systolic blood pressure control (Cardio-Sis): rationale, design and characteristics of the study population. Cardio-Sis Study Group J Hum Hypertens; 2008 Apr; 22(4):243-51. PubMed ID: 18046432 [TBL] [Abstract][Full Text] [Related]
38. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials. Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL; Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169 [TBL] [Abstract][Full Text] [Related]
39. Cranberry does not affect prothrombin time in male subjects on warfarin. Li Z; Seeram NP; Carpenter CL; Thames G; Minutti C; Bowerman S J Am Diet Assoc; 2006 Dec; 106(12):2057-61. PubMed ID: 17126638 [TBL] [Abstract][Full Text] [Related]
40. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study. Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z; Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]